Dr. Kimball leads Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center, serving as a strategist, patient and physician advocate, clinical innovator and accessible leader. She has driven nearly 50% growth during her nine-year tenure as CEO, with the organization surpassing $1 billion in annual revenue in 2025. In 2025 alone, she helped recruit 340 new physicians and created the recruitment infrastructure for the physician group’s revolutionary 60-year, $1.7 billion collaboration with Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center in Boston, supporting the successful hiring of nearly 50 faculty within six months. Equally defining is her commitment to physician wellbeing, with the American Medical Association’s 2025 “Joy in Medicine” survey finding that from 2024 to 2025 physician stress fell 21.8%, burnout declined 8.5%, and intent to leave within two years dropped 9.3% at the physician group. A practicing dermatologist and clinical researcher, Dr. Kimball has conducted more than 150 clinical trials as principal investigator, contributed academic work on biomarkers that has directly shaped treatment pathways for severe chronic conditions, and helped develop drugs for underserved medical conditions through industry partnerships. She has also launched leadership training courses for physicians nationwide, negotiated directly with payers to ensure fair physician compensation, and championed gender equity in academic medicine through published advocacy. Dr. Kimball serves as physician chair of the Beth Israel Lahey Health Performance Network board of managers, and on the boards of Beth Israel Lahey Health, Beth Israel Deaconess Medical Center, the American Skin Association and the American Dermatologic Association.
